PHILADELPHIA, April 29, 2021 /PRNewswire/ — FinPay LLC, a recognized leader in pre-care payments and patient engagement announced today the addition of Eric May as the Vice President of Product. Prior to joining FinPay, Eric spent six years leading the product engineering team at BizEquity, the world’s leading and only patented online business valuation service.
“We are thrilled to have Eric join the leadership team at FinPay,” stated Tim Kowalski, President and CEO of FinPay. “Our technology platform is an industry leader in driving increased patient engagement and patient financial responsibility capture. Eric has a deep appreciation for what it takes to successfully scale enterprise-ready products and the teams behind those products, which is exactly what FinPay needs as our growth continues to accelerate.”
“I believe that diverse and empowered product teams that have clear objectives deliver the best results and value to our customers,” said Eric. “I’m excited to join a team that has a strong foundation and a culture that ensures each team member’s success as we work towards organizational goals. I’m looking forward to helping the team scale, mature and advance patient financial management in healthcare.”
While serving as Vice President of Product at BizEquity, Eric focused on building high-performance teams with organizational and process maturity. Eric has a passion for aligned objectives at every level of the product team, specifically to empower decision-making by those closest to the work. Eric brings more than 25 years of FinTech industry experience to FinPay.
Eric holds a Masters from Penn State Great Valley in Information Science and a BS from Penn State University in Logistics.
About FinPay
FinPay is committed to solving the affordability crisis in healthcare by enhancing the patient financial experience through pre-care engagement, expanding healthcare financial literacy, advocating for cost transparency, and improving patient’s access to affordable healthcare.
Media Contact
Stacy McCloskey
Director of Marketing
stacy.mccloskey@finpay.net
SOURCE FinPay, LLC
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…